Tanja de Gruijl

PROF.DR., PhD, (Principal Investigator)

19962019
If you made any changes in Pure these will be visible here soon.

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1996 2019

Chemically engineered glycan-modified cancer vaccines to mobilize skin dendritic cells

Duinkerken, S., Li, RJE., van Haften, F. J., de Gruijl, TD., Chiodo, F., Schetters, STT. & van Kooyk, Y., 1 Dec 2019, In : Current Opinion Chemical Biology. 53, p. 167-172 6 p.

Research output: Contribution to journalReview articleAcademicpeer-review

Glycan-modified melanoma-derived apoptotic extracellular vesicles as antigen source for anti-tumor vaccination

Horrevorts, S. K., Stolk, D. A., van de Ven, R., Hulst, M., van Het Hof, B., Duinkerken, S., Heineke, M. H., Ma, W., Dusoswa, S. A., Nieuwland, R., Garcia-Vallejo, J. J., van de Loosdrecht, A. A., de Gruijl, T. D., van Vliet, S. J. & van Kooyk, Y., 1 Sep 2019, In : Cancers. 11, 9, 1266.

Research output: Contribution to journalArticleAcademicpeer-review

Open Access

Activities 2013 2018

  • 2 Editorial work

Clinical and Experimental Immunology (Journal)

Tanja de Gruijl (Reviewer)
1 Jan 2018

Activity: Publication peer-review and editorial workEditorial work

Cancer Immunology Research (Journal)

Tanja de Gruijl (Reviewer)
2013

Activity: Publication peer-review and editorial workEditorial work